News & Updates

32 Biosciences receives $6 million in funding to advance gut microbiome platform technologies

June 19, 2025

Published by Microbiome Times

32 Biosciences announced it has received $6 million in funding to support the continued development of its lead assets. The funding comes as the company prepares for a future Series

32 Biosciences Raises $6M, Advances Gut Microbiome Diagnostics Toward FDA Clearance

June 11, 2025

Published by iBio

Chicago-based biotech exceeds fundraising goals while building leadership team for regulatory milestones

Chicago startup 32 Biosciences raises $6 million, eyes FDA approval next

June 11, 2025

Published by Chicago Business Journal

A Chicago-based biotech startup is making waves in the gut health industry, securing millions in funding to advance its innovative microbiome tools.

32 Biosciences Surpasses Financing Target, Accelerates Toward Series A and FDA Milestones 

June 10, 2025

Published by Business Wire

Microbiome-focused company receives $6 million in funding to advance gut health platform technologies.

Microbiota-dependent Early-life Programming of Gastrointestinal Motility

October 19, 2024

Published by iScience

Gastrointestinal microbes modulate peristalsis and stimulate the enteric nervous system (ENS), whosedevelopment, as in the central nervous system (CNS), continues into the murine postweaning period.Given that adult CNS function depends

UChicago Microbiome Startups Come Together Under New Company to Amplify Results

September 27, 2024

Published by Polsky Center for Entrepreneurship and Innovation

Two University of Chicago startups are now operating under a parent company, 32 Biosciences – with a shared goal to revolutionize health care through advances in microbiome science. The name

2 UChicago Gut Science Startups Form New Entity

September 13, 2024

Published by Crain’s Chicago Business

32 Biosciences Emerges from Stealth Mode with New Approach to Gut Microbiome Medicine

September 12, 2024

Published by PR Newswire

32 Biosciences, pronounced “Three Squared Biosciences,” proudly announces its emergence from stealth mode, with new microbiome diagnostic management tools and microbiome-based interventions. The company intends to revolutionize healthcare with its

Preventing Surgical Site Infections in the Era of Escalating Antibiotic Resistance and Antibiotic Stewardship

August 2, 2024

Importance: According to the Centers for Disease Control and Prevention and governing bodies within the American College of Surgeons, the administration of antibiotics as prophylaxis against infection prior to a planned